Dr Amy Walker

4basebio has announced Dr Amy Walker as Chief Operating Officer

4basebio has announced the appointment of Dr Amy Walker as Chief Operating Officer of the company.

Amy joined 4basebio in November 2020 and has served as the Vice President of Research and Business Development at the company.

She has a background in molecular biology and gene editing technologies, along with associated nucleic acid nanoparticle delivery platforms.

Amy has many years scientific and commercial experience in life sciences, has published scientific papers and is named inventor on numerous multidisciplinary patents.

She currently holds non-executive director Board positions on two other high growth healthcare companies.

Meanwhile, the company has also formed a Strategic Advisory Board, with the purpose of offering the company’s leadership team valuable advice and industry insight spanning technical, operational, commercial and strategic matters as well as supporting the company in the realisation of its growth goals and objectives.

The members include Deborah Barbara, Lawrence Pitcher and Bertrand Coissac.